Edwards Lifesciences EBITDA 2010-2025 | EW
Edwards Lifesciences annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Edwards Lifesciences EBITDA for the quarter ending March 31, 2025 was $0.431B, a 11.33% increase year-over-year.
- Edwards Lifesciences EBITDA for the twelve months ending March 31, 2025 was $1.578B, a 11.29% increase year-over-year.
- Edwards Lifesciences 2024 annual EBITDA was $1.534B, a 5.51% increase from 2023.
- Edwards Lifesciences 2023 annual EBITDA was $1.454B, a 11.25% decline from 2022.
- Edwards Lifesciences 2022 annual EBITDA was $1.638B, a 10.25% decline from 2021.
| Edwards Lifesciences Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,534 |
| 2023 | $1,454 |
| 2022 | $1,638 |
| 2021 | $1,825 |
| 2020 | $1,005 |
| 2019 | $1,236 |
| 2018 | $826 |
| 2017 | $1,171 |
| 2016 | $855 |
| 2015 | $709 |
| 2014 | $561 |
| 2013 | $535 |
| 2012 | $474 |
| 2011 | $358 |
| 2010 | $341 |
| 2009 | $297 |
| Edwards Lifesciences Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $431 |
| 2024-12-31 | $353 |
| 2024-09-30 | $385 |
| 2024-06-30 | $409 |
| 2024-03-31 | $388 |
| 2023-12-31 | $328 |
| 2023-09-30 | $403 |
| 2023-06-30 | $300 |
| 2023-03-31 | $424 |
| 2022-12-31 | $233 |
| 2022-09-30 | $438 |
| 2022-06-30 | $494 |
| 2022-03-31 | $474 |
| 2021-12-31 | $407 |
| 2021-09-30 | $424 |
| 2021-06-30 | $578 |
| 2021-03-31 | $416 |
| 2020-12-31 | $384 |
| 2020-09-30 | $383 |
| 2020-06-30 | $-145 |
| 2020-03-31 | $383 |
| 2019-12-31 | $335 |
| 2019-09-30 | $317 |
| 2019-06-30 | $289 |
| 2019-03-31 | $295 |
| 2018-12-31 | $15 |
| 2018-09-30 | $268 |
| 2018-06-30 | $271 |
| 2018-03-31 | $272 |
| 2017-12-31 | $326 |
| 2017-09-30 | $248 |
| 2017-06-30 | $268 |
| 2017-03-31 | $330 |
| 2016-12-31 | $191 |
| 2016-09-30 | $214 |
| 2016-06-30 | $233 |
| 2016-03-31 | $218 |
| 2015-12-31 | $189 |
| 2015-09-30 | $174 |
| 2015-06-30 | $164 |
| 2015-03-31 | $181 |
| 2014-12-31 | $169 |
| 2014-09-30 | $148 |
| 2014-06-30 | $135 |
| 2014-03-31 | $110 |
| 2013-12-31 | $145 |
| 2013-09-30 | $123 |
| 2013-06-30 | $141 |
| 2013-03-31 | $126 |
| 2012-12-31 | $155 |
| 2012-09-30 | $109 |
| 2012-06-30 | $110 |
| 2012-03-31 | $100 |
| 2011-12-31 | $101 |
| 2011-09-30 | $74 |
| 2011-06-30 | $90 |
| 2011-03-31 | $93 |
| 2010-12-31 | $96 |
| 2010-09-30 | $81 |
| 2010-06-30 | $87 |
| 2010-03-31 | $77 |
| 2009-12-31 | $79 |
| 2009-09-30 | $72 |
| 2009-06-30 | $77 |
| 2009-03-31 | $69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.221B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.295B | 84.22 |
| Thermo Fisher Scientific (TMO) | United States | $152.179B | 18.41 |
| Alcon (ALC) | Switzerland | $47.228B | 31.39 |
| IDEXX Laboratories (IDXX) | United States | $39.544B | 45.44 |
| DexCom (DXCM) | United States | $33.200B | 51.32 |
| IQVIA Holdings (IQV) | United States | $25.775B | 14.44 |
| Mettler-Toledo (MTD) | United States | $22.466B | 26.72 |
| STERIS (STE) | Ireland | $22.247B | 25.44 |
| Waters (WAT) | United States | $20.475B | 28.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.744B | 0.00 |
| Hologic (HOLX) | United States | $12.646B | 13.74 |
| Penumbra (PEN) | United States | $11.514B | 90.37 |
| Sysmex ADR (SSMXY) | Japan | $11.482B | 0.00 |
| Masimo (MASI) | United States | $8.489B | 31.31 |
| Globus Medical (GMED) | United States | $7.678B | 18.01 |
| Teleflex (TFX) | United States | $5.528B | 9.13 |
| Glaukos (GKOS) | United States | $5.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.133B | 21.65 |
| TransMedics (TMDX) | United States | $3.771B | 81.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.327B | 32.65 |
| Nihon Kohden (NHNKY) | Japan | $2.040B | 11.15 |
| Elekta AB (EKTAY) | Sweden | $1.943B | 17.47 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.531B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.952B | 5.06 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 14.71 |
| IRadimed (IRMD) | United States | $0.659B | 33.46 |
| Beta Bionics (BBNX) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.10 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| RxSight (RXST) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.518B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.473B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.422B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.09 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.222B | 13.44 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.201B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.159B | 0.00 |
| Accuray (ARAY) | United States | $0.156B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.22 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.64 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |